Skip to content
  • Health Library
  • Find a Doctor
  • Refer a Patient
  • News
  • Careers

Consult QD - A site for physicians and healthcare professionals from Cleveland Clinic. Discover the latest research insights, innovations, treatment trends and more.

Search
Primary Menu ☰
  • Specialties
    • Behavioral Health
    • Cancer
    • Dermatology & Plastic Surgery
    • Diabetes & Endocrinology
    • Digestive
    • Geriatrics
    • Heart, Vascular & Thoracic
    • Neurosciences
    • Nursing
    • Ob/Gyn & Women’s Health
    • Ophthalmology
    • Orthopaedics
    • Otolaryngology & Dentistry
    • Pain Management
    • Pathology
    • Pediatrics
    • Primary Care
    • Pulmonary & Critical Care
    • Rheumatology & Immunology
    • Urology & Nephrology
  • Peer-to-Peer Insights
    • Basic & Translational Science
    • Bioethics
    • COVID-19
    • Functional Medicine
    • Genomic Medicine
    • Global Medicine
    • Health Information Technology
    • Leadership
    • Professional Fulfillment
    • Transplant
  • Resources
    • Cleveland Clinic Alumni
    • Cleveland Clinic Caregiver Office
    • Cleveland Clinic Florida
    • Cleveland Clinic Journal of Medicine
    • Cleveland Clinic London
    • CME
    • Consult QD Live
    • Institutes & Services
    • Outcomes
    • Resources For Medical Professionals

Research

Feb. 22, 2023 / Genomic Medicine / Research

Determining Autism, Cancer Risk in Patients with PTEN Hamartoma Tumor Syndrome

Studying the relationship between autism spectrum disorder and cancer in individuals affected by PTEN hamartoma tumor syndrome is the subject of a new $2 million grant awarded from the National Institutes of Health to Charis Eng, MD, PhD, Chair of the Genomic Medicine Institute.

Read More
Determining Autism, Cancer Risk in Patients with PTEN Hamartoma Tumor Syndrome
Nov. 30, 2021 / Genomic Medicine / Research

New Clinic Helps Cancer Patients Decipher Results of Genome Sequencing

New virtual genomics clinic provides custom-tailored cancer treatments by targeting specific molecular alterations in patients’ tumors.

Sep. 5, 2018 / Genomic Medicine / Research

The Microbiome in PTEN Hamartoma Tumor Syndrome

A new study provides initial evidence that differences in gut microbiota composition may indicate whether or not a PHTS patient will develop cancer.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

ConsultQD

A site for physicians and healthcare professionals. Discover Cleveland Clinic’s latest research insights, innovations, treatment trends and more.

Advertising Policy
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • LinkedIn
  • Pinterest
  • Snapchat

Cleveland Clinic

  • Home
  • About Cleveland Clinic
  • Careers at Cleveland Clinic
  • Giving
  • Office of Diversity & Inclusion
  • Community Outreach
  • Research & Innovations
  • Health Library
  • Free Health eNewsletters
  • Resources for Medical Professionals
  • Media Relations

Social Media & Mobile Apps

  • Send Us Feedback
  • About this Website
  • Advertising Policy
  • Social Media Policy
  • Copyright, Reprints & Licensing
  • Website Terms of Use
  • Website Privacy Policy
  • Notice of Privacy Practices
  • Non-Discrimination Notice

Resources

  • Mobile Apps
  • Podcasts
Cleveland Clinic © 1995-2023. All Rights Reserved. 9500 Euclid Avenue , Cleveland , Ohio 44195 | 800.223.2273 | TTY 216.444.0261